当前位置: 首页 > 期刊 > 《医学信息》 > 2019年第23期
编号:13450513
糖尿病痛性神经病变危险因素的研究(6)
http://www.100md.com 2019年6月11日 《医学信息》 2019年第23期
     [35]Basit A,Basit KA,Fawwad A,et al.Vitamin D for the treatment of painful diabetic neuropathy[J].BMJ Open Diabetes Res Care,2016,4(1):e000148.

    [36]Galer B,Gianas A,Jensen MP.Painful diabetic polyneuropathy,epidemiology,pain description and quality of life[J].Diabetes Res Clin Pract,2000,47(2):123-128.

    [37]Cheng KI,Lin SR,Chang LL,et al.Association of the functional A118G polymorphism of OPRM1 in diabetic patients with foot ulcer pain[J].J Diabetes Complications,2010,24(2):102-108.

    [38]Meng W,Deshmukh HA,Donnelly LA,et al.A Genome-wide Association Study Provides Evidence of Sex-specific Involvement of Chr1p35.1 (ZSCAN20-TLR12P) and Chr8p23.1 (HMGB1P46) With Diabetic Neuropathic Pain[J].EBioMedicine,2015,2(10):1386-1393.

    [39]Meng W,Deshmukh HA,Van Zuydam NR,et al.A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic pain[J].Eur J Pain,2015,19(3):392-399.

    [40]Ursu D,Ebert P,Langron E,et al.Gain and loss of function of P2X7receptors:mechanisms,pharmacology and relevance to diabetic neuropathic pain[J].Mol Pain,2014(10):37.

    收稿日期:2019-9-9;修回日期:2019-9-23

    編辑/杜帆, http://www.100md.com(丁胜兰 刘智平)
上一页1 2 3 4 5 6